IRS Special Agent Jeff Novitsky has been transferred to the Food and Drug Administration (FDA) Office of Criminal Investigations as a special agent to give him greater freedom to focus on anabolic steroid-related investigations (“No Longer With I.R.S., Novitzky Joins F.D.A.,” April 23).
In regards to Novitzky’s new job, Dwight Sparlin, a retired I.R.S. manager who led the San Francisco office when the Balco case started nearly six years ago, said he had been hearing for two weeks that Novitzky was going to the F.D.A. to continue focusing on drug cases.
“I think it would give him more exposure to just doing that type of work,” Sparlin said by telephone Tuesday. He added: “For Jeff to go as far as he did in Balco was a stretch for the I.R.S., too. I think he was allowed to go a lot further than he would otherwise because of the impact.”
Jeff Novitsky has been involved in almost every aspect of the BALCO steroid scandal and steroids in baseball investigation.
(Hat tip to Steroid Nation for the story.)
About the author
Millard writes about anabolic steroids and performance enhancing drugs and their use and impact in sport and society. He discusses the medical and non-medical uses of anabolic-androgenic steroids while advocating a harm reduction approach to steroid education.
Leave a Reply
You must be logged in to post a comment.